Sur vs Tunisia: HIV-positive TB patients on ART (antiretroviral therapy)
Sur
82.0%
in 2024
Tunisia
100.0%
in 2023
Sur rank
2nd
Tunisia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sur
- Tunisia
How they compare
Tunisia currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Tunisia's figure about 1.2 times Sur's.
Across all 17 years both countries report, Tunisia has been ahead every year.
Sur ranks 2nd and Tunisia ranks 1st of 2 regions.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sur | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 27.5% | 100.0% | 72.5% | Tunisia |
| 2010s | 63.8% | 100.0% | 36.2% | Tunisia |
| 2020s | 74.2% | 100.0% | 25.8% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sur or Tunisia?
- Tunisia, at 100.0% against 82.0% in Sur as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sur and Tunisia?
- 18.0%, with Tunisia ahead.
- How many years of comparable data are there for Sur and Tunisia?
- 17 years are reported by both, from 2003 to 2023.
- How do Sur and Tunisia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sur ranks 2nd and Tunisia ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.